Chugai Pharmaceutical Co., Ltd. Share Price
Stocks
4519
JP3519400000
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
07:30:00 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 6,089.00 JPY | +0.94% |
|
-7.97% | -26.13% |
| 09-23 | Chugai Pharma to Boost Capex by 50% to Expand In-House Production | MT |
| 08-21 | Alvotech Enters Licensing, Commercialization Deal for Two Biosimilars in US, Certain Asian Markets | MT |
| Market Cap | 10,018B 63.41B 56.57B 52.7B 47.96B 90.31B 6,107B 90.98B 637B 248B 3,117B 238B 233B | P/E 2026 * |
19.9x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 9,107B 57.64B 51.42B 47.91B 43.6B 82.1B 5,551B 82.71B 579B 225B 2,833B 216B 212B | EV / Sales 2026 * |
6.59x | EV / Sales 2027 * | 5.81x |
| Free-Float |
38.12% | Yield 2026 * |
2.21% | Yield 2027 * | 2.54% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4519 | Delayed | |
OTC Markets
| CHGCF | Delayed | |
|
Mexican S.E.
| 4519 N | End-of-day quote | |
|
Tradegate
| CUP | Real-time | |
|
Boerse Muenchen
| CUP | Real-time | |
|
Deutsche Boerse AG
| CUP | Delayed | |
|
Börse Stuttgart
| CUP | Delayed |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +0.94% | ||
| 1 week | -7.97% | ||
| Current month | -2.18% | ||
| 1 month | -10.39% | ||
| 3 months | -20.32% | ||
| 6 months | -30.64% | ||
| Current year | -26.13% |
| 1 week | 5,974 |  | 6,340 |
| 1 month | 5,974 | | 6,804 |
| Current year | 5,974 | | 10,700 |
| 1 year | 5,974 | | 10,700 |
| 3 years | 4,234 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 28/02/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 27/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 29/02/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 27/03/2024 |
| Director/Board Member | 51 | 28/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.94% | -7.97% | -12.75% | +38.67% | 62.92B | |
| +1.09% | -2.60% | +36.55% | +113.11% | 1,019B | |
| -0.83% | -6.59% | +35.00% | +61.65% | 617B | |
| +0.40% | -0.88% | +14.66% | +79.00% | 464B | |
| -2.84% | -5.66% | +57.97% | +35.40% | 356B | |
| +0.93% | -1.83% | +20.98% | +41.43% | 333B | |
| +0.12% | -4.05% | +10.09% | +33.53% | 267B | |
| -0.89% | -5.83% | -7.56% | +7.91% | 244B | |
| +0.11% | -3.62% | +37.02% | +52.03% | 218B | |
| -0.26% | -5.20% | +27.04% | +93.17% | 179B | |
| Average | -0.21% | -4.07% | +21.90% | +55.59% | 376.01B | |
| Weighted average by Cap. | -0.09% | -3.63% | +28.26% | +68.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,383B 8.75B 7.81B 7.27B 6.62B 12.46B 843B 12.56B 87.88B 34.19B 430B 32.85B 32.14B | 1,526B 9.66B 8.61B 8.03B 7.3B 13.75B 930B 13.86B 96.97B 37.73B 475B 36.25B 35.47B |
| Net income | 504B 3.19B 2.85B 2.65B 2.41B 4.55B 307B 4.58B 32.06B 12.47B 157B 11.98B 11.73B | 581B 3.68B 3.28B 3.06B 2.78B 5.24B 354B 5.27B 36.92B 14.36B 181B 13.8B 13.5B |
| Net Debt | -911B -5.77B -5.14B -4.79B -4.36B -8.21B -555B -8.28B -57.92B -22.53B -283B -21.65B -21.18B | -1,150B -7.28B -6.49B -6.05B -5.51B -10.37B -701B -10.45B -73.11B -28.45B -358B -27.33B -26.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | JP¥6,089.00 | +0.94% | 3,878,500 |
| 02/10/26 | JP¥6,032.00 | -2.32% | 4,546,000 |
| 01/10/26 | JP¥6,175.00 | -0.80% | 4,383,000 |
| 30/09/26 | JP¥6,225.00 | +2.12% | 9,460,400 |
| 29/09/26 | JP¥6,096.00 | -4.18% | 4,741,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
